September 2, 2026 · 9 min read
Who Decided This Cancer Drug Costs $477,600?
Daraxonrasib is a real pancreatic cancer advance. Its price shows what happens when a company names the starting number and the payer cannot easily walk away.
Read issueThe CareCore Stack
Archive
Clinical evidence, market structure, and the operating choices shaping care.
June 26, 2026 · 4 min read
Welcome to The CareCore Stack
A doctor's note on the quest to fix healthcare.
Read issueMay 1, 2026 · 6 min read
Peptides are not the product
Peptides are where longevity medicine's demand curve collides with pharmacy quality, regulatory process, and clinical governance.
Read issue